Research News and Research

RSS

Special hearing on potential environmental health factors associated with autism spectrum disorders

Autism Speaks' Chief Science Officer Geraldine Dawson, Ph.D. emphasized the importance of research on environmental risk factors for autism spectrum disorders as the U.S. Senate Committee on Environment & Public Works, Subcommittee on Children's Health convened a special hearing on potential environmental health factors associated with autism spectrum disorders (ASD) and related neurodevelopmental disorders. The hearing is examining the latest research on potential environmental factors that may increase the risk for autism spectrum disorders.

4 Aug 2010

Master model to track mercury movement from original emission source to humans

University of Louisville Public Health doctoral student Caroline Chan is working to create scientific tools to help environmental policy decision makers evaluate and modify mercury emission regulations.

3 Aug 2010

Impax Laboratories total revenue for second-quarter 2010 increases to $153.1 million

Impax Laboratories, Inc. today reported strong growth in the second quarter of 2010 due to an increase in sales from its Global Product sales channel. Total revenue increased $94.7 million to $153.1 million driven by continued strong sales of generic Adderall XR and generic Flomax for which there were no amounts in the second quarter of 2009, as well as increased sales of the Company's fenofibrate products.

3 Aug 2010

MAP Pharmaceuticals reports net loss of $12.5M for second-quarter 2010

MAP Pharmaceuticals, Inc. today announced financial results for the second quarter ended June 30, 2010.

3 Aug 2010

Sangon Biotech, Bio Basic complete $10 million round of funding from Qiming Ventures

Sangon Biotech, a Shanghai based life science research service company, and Bio Basic Inc. (BBI), a Toronto based life science research service company, announced today the completion of a $10 million round of funding from Qiming Ventures. The company is using the funding to scale research & development, marketing and sales of its life science research tools including biochemical reagents, protein, antibody, research kit, DNA synthesis service, etc. to meet increasing demand.

3 Aug 2010

AGA Medical second-quarter 2010 net sales increase 7.6% to $53.8 million

AGA Medical Holdings, Inc., a leading developer of interventional medical devices for the minimally invasive treatment of structural heart defects and vascular abnormalities, today reported financial results for the second quarter ended June 30, 2010.

3 Aug 2010

ImpactRx launches smart-phone application for physicians

ImpactRx, Inc., the pioneering force in measuring the impact of pharmaceutical promotion on the behavior of the nation's highest prescribing physicians, today announced the launch of an application for physicians that provides pharmaceutical companies with timely and actionable insight into drug therapy promotion and treatment activity. ImpactRx is leveraging the capabilities of this newly available smart-phone application by using iPhone with its longitudinal physician network.

3 Aug 2010

Curis reports net loss of $2.1 million for second-quarter 2010

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today reported its financial results for the second quarter ended June 30, 2010.

3 Aug 2010

Titan completes 60% enrollment in confirmatory Phase 3 clinical study of Probuphine for opioid addiction

Titan Pharmaceuticals, Inc. today announced that patient enrollment is more than 60% complete in the confirmatory Phase 3 clinical study of Probuphine for the treatment of opioid addiction, and the study is expected to complete enrollment by early fourth quarter of this year, which is almost three months ahead of schedule.

3 Aug 2010

West Pharmaceutical Services second-quarter gross profit increases 5.8% to $83.2 million

West Pharmaceutical Services, Inc. today announced its financial results for the second quarter of 2010.

3 Aug 2010

Caliper Life Sciences second-quarter GAAP revenue decreases 10% to $29.0 million

Caliper Life Sciences, Inc., today reported results for its second quarter ended June 30, 2010. Second quarter GAAP revenue decreased 10% to $29.0 million from $32.1 million in the same period in 2009 as a result of divestitures in 2010 and 2009. Revenue from on-going business increased 4% on a reported basis and 6% on an organic basis (which assumes constant currency).

3 Aug 2010

First Edition: August 3, 2010

Today's headlines include reports about a federal judge's ruling regarding the Virginia challenge to the health reform law and about the Senate's latest delay in consideration of a state aid package that includes Medicaid assistance.

3 Aug 2010

Vical second-quarter revenues decrease to $2.1 million

Vical Incorporated today reported financial results for the three months and six months ended June 30, 2010. Revenues decreased to $2.1 million for the second quarter of 2010 from $4.0 million for the second quarter of 2009, primarily as a result of a $1.5 million milestone payment in 2009 from Merck & Co., Inc., based on Merck's ongoing Phase 1 clinical-stage development of an investigational cancer vaccine.

3 Aug 2010

Acorda second-quarter net loss decreases to $6.8 million

Acorda Therapeutics, Inc. today announced its financial results for the second quarter of 2010.

3 Aug 2010

Effects of natural compound against prostate cancer published in Integrative Cancer Therapies

Researchers at Columbia University have published the dramatic effects of a natural 33-ingredient compound against prostate cancer cell lines. The impressive results are found in the most recent publication of Integrative Cancer Therapies.

3 Aug 2010

Insulin resistance from obesity leads to lower cognitive performance in children: Research

A study by researchers at NYU Langone Medical Center have found that obese adolescents with type 2 diabetes have diminished cognitive performance and subtle abnormalities in the brain as detected by Magnetic Resonance Imaging (MRI). Identification of cognitive impairments as a complication of type 2 diabetes emphasizes the importance of addressing issues of inactivity and obesity, two important risk factors for the development of the disease among the young.

3 Aug 2010

First patient treated in Phase Ib expansion study of CUDC-101

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the first patient has been treated in a Phase Ib expansion study for CUDC-101 in patients with advanced head and neck, gastric, breast and liver cancers.

3 Aug 2010

Combat veterans face challenges at high rates than non-veterans: Research

From the many images sent home from foreign battlefields over the last several decades, Americans have viewed the plight of their country's combat-weary veterans as stark and often iconic scenes that seem somehow frozen in time. But recent research at Washington State University suggests that, for many U.S. veterans, combat is a defining experience that often sets the trajectory of the balance of their lives.

3 Aug 2010

Elsevier makes available key articles in support of World Breastfeeding Week 2010

In support of World Breastfeeding Week 2010, Elsevier - the world-leading publisher of scientific, technical and medical information products and services - is pleased to open access to selected articles related to breastfeeding from the Journal of Midwifery & Women's Health, Midwifery and the Journal of Pediatric Health Care. Midwives and pediatric nurse practitioners play a central role in supporting and advocating for breastfeeding.

3 Aug 2010

Axiogenesis signs non-exclusive license agreement with iPS Academia

Axiogenesis AG and iPS Academia Japan Inc. (Kyoto, Japan) announced that they have executed a non-exclusive agreement with iPS Academia (Kyoto, Japan) through which Axiogenesis obtains worldwide access to the extensive portfolio of induced pluripotent stem cell technology for iPSC-derived cardiomyocytes and other cell types, pioneered by Professor Shinya Yamanaka, Center for iPS Cell Research and Application at the University of Kyoto, Japan.

3 Aug 2010

Research News and Research

Special hearing on potential environmental health factors associated with autism spectrum disorders

Master model to track mercury movement from original emission source to humans

Impax Laboratories total revenue for second-quarter 2010 increases to $153.1 million

MAP Pharmaceuticals reports net loss of $12.5M for second-quarter 2010

Sangon Biotech, Bio Basic complete $10 million round of funding from Qiming Ventures

AGA Medical second-quarter 2010 net sales increase 7.6% to $53.8 million

ImpactRx launches smart-phone application for physicians

Curis reports net loss of $2.1 million for second-quarter 2010

Titan completes 60% enrollment in confirmatory Phase 3 clinical study of Probuphine for opioid addiction

West Pharmaceutical Services second-quarter gross profit increases 5.8% to $83.2 million

Caliper Life Sciences second-quarter GAAP revenue decreases 10% to $29.0 million

First Edition: August 3, 2010

Vical second-quarter revenues decrease to $2.1 million

Acorda second-quarter net loss decreases to $6.8 million

Effects of natural compound against prostate cancer published in Integrative Cancer Therapies

Insulin resistance from obesity leads to lower cognitive performance in children: Research

First patient treated in Phase Ib expansion study of CUDC-101

Combat veterans face challenges at high rates than non-veterans: Research

Elsevier makes available key articles in support of World Breastfeeding Week 2010

Axiogenesis signs non-exclusive license agreement with iPS Academia

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence